Skip to main content

Hansoh Pharmaceutical Group

Hansoh Pharmaceutical Group Company Limited is a research-driven biopharmaceutical company in China engaged in the development, manufacturing, and commercialization of innovative small-molecule therapies and biologics. The company focuses on major therapeutic areas, including oncology, central nervous system disorders, metabolic diseases, autoimmune conditions, and anti-infectives. Primary revenue drivers include the commercial sales of proprietary innovative prescription drugs and high-value generic formulations across domestic clinical markets. Hansoh Pharmaceutical serves hospitals, medical centers, specialty clinics, and retail pharmacy networks throughout mainland China. The enterprise holds a top-tier position among domestic Chinese biopharmaceutical innovators, supported by extensive research and clinical trial capabilities. Hansoh Pharmaceutical Group Company Limited is headquartered in Lianyungang, China, and its common shares are listed on the Stock Exchange of Hong Kong.

22 of the funds FundTelligence covers report a position in Hansoh Pharmaceutical Group.

Legal name
Hansoh Pharmaceutical Group Co Ltd
Sector
Health Care
Country
China
Funds holding it
22

Funds holding Hansoh Pharmaceutical Group

Showing the 8 largest of 22 funds holding it.

Loading...